(S)-2-Amino-3-(3-hydroxy-phenyl)-propionic acid; hydrochloride | 195050-48-7

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: (S)-2-Amino-3-(3-hydroxy-phenyl)-propionic acid; hydrochloride
• 英文别名: (S)-2-Amino-3-(3-hydroxyphenyl)propanoic acid hcl；(2S)-2-amino-3-(3-hydroxyphenyl)propanoic acid;hydrochloride
• CAS: 195050-48-7
• 化学式: C₉H₁₁NO₃*ClH
• 分子量: 217.652
• InChiKey: ISUKJARAXHJOJA-QRPNPIFTSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.77
• 重原子数：
  14
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  83.6
• 氢给体数：
  4
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  5-羟基-2-硝基苯甲醇 在 palladium on activated charcoal 盐酸 、 lithium hydroxide 、 sodium hydroxide 、 sodium tetrahydroborate 、 氢气 、 四丁基硫酸氢铵 、 sodium hydride 、 溶剂黄146 、 三乙胺 、 sodium iodide 、 亚硝酸异戊酯 作用下， 以 四氢呋喃 、 甲醇 、 乙醇 、 二氯甲烷 、 N,N-二甲基甲酰胺 、 丙酮 为溶剂， 40.0 ℃ 、453.3 Pa 条件下， 反应 13.67h， 生成 (S)-2-Amino-3-(3-hydroxy-phenyl)-propionic acid; hydrochloride
  参考文献：
  名称：

  Design of New Photoactivatable Amino Acids: Stereoselective Synthesis of N-Protected Phenylalanine Derivatives as Precursors of p-Diazocyclohexadienone-Containing Peptides

  摘要：

  4-Diazocyclohexa-2,5-dienone-based amino acids m-Dip and o-Dip were designed for building up photoactivatable peptides. Their stable precursors L-3-[3-(benzyloxy)-6-nitrophenyl]alanine (L-m-Nip(Bn)) and L-3-[2-(benzyloxy)-5-nitrophenyl]alanine (L-o-Nip(Bn)) were synthesized by stereoselective alkylation of the corresponding benzyloxynitrobenzyl iodides by a chiral glycine equivalent. Alkylation was carried out using either butyllithium in dry organic solvents or a phase transfer procedure. Alkylation, hydrolysis of the adduct, and protection as Boc and Fmoc derivatives were achieved in 57-73% overall yields and led to 97-99% optically pure material. Boc or Fmoc-m/o-Nip(Bn) was inserted in model dipeptides Ac-mlo-Nip(Bn)-Ala-OMe or tripeptides Ala-Lm-Nip-(Bn)-Lys and Ala-L-o-Nip(Bn)-Arg, respectively, by homogeneous solution procedure and by solid-phase peptide synthesis. Deprotection and diazotization of the resulting p-hydroxyanilines gave the corresponding photoactivatable 4-diazocyclohexa-2,5-dienones containing peptides in quantitative yields. Such photoprobes are stable for several hours in the dark but are rapidly photolyzed at 350 nm or at 295 nm by a tryptophan-mediated energy transfer activation process.

  DOI：

  10.1021/jo00108a023

文献信息

• [EN] N-ACYL AMINO ACID COMPOUNDS AND METHODS OF USE<br/>[FR] COMPOSÉS D'ACIDES AMINÉS N-ACYLE ET MÉTHODES D'UTILISATION
  申请人：PLIANT THERAPEUTICS INC

  公开号：WO2018049068A1

  公开（公告）日：2018-03-15

  The invention relates to compounds of formula (I), or a salt thereof wherein R1, A, L, and R2 and n are as described herein. Compounds of formula (I) and pharmaceutical compositions thereof are ανβ1 integrin inhibitors that are useful for treating tissue specific fibrosis.

  该发明涉及式(I)的化合物或其盐，其中R1、A、L、R2和n如本文所述。式(I)的化合物及其药物组成物是ανβ1整合素抑制剂，可用于治疗特定组织纤维化。
• Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
  申请人：Fujisawa Pharmaceutical Co. Ltd.

  公开号：US20020143034A1

  公开（公告）日：2002-10-03

  A compound of the formula (I): 1 wherein X 1 is bond or —OCH 2 —; X 2 is —(CH 2 ) n —, in which n is 1, 2 or 3; X 3 is bond, —O—, —S—, —OCH 2 —, or —NH—; R 1 is phenyl or pyridyl each of which may have one or two substituent(s) selected from the group consisting of hydroxy, halogen, etc.; R 2 is hydrogen, (lower)alkoxycarbonyl, etc.; R 3 is hydroxy(lower)alkyl; halo(lower)alkyl, etc.; R 4 is aryl or unsaturated heterocyclic group, each of which may have one or two substituent(s) selected from the group consisting of lower alkyl, hydroxy, carbamoyl, halogen, lower alkoxy, etc.; and a salt thereof which is useful as a medicament.

  该化合物的结构式如下：其中X1是化学键或—OCH2—；X2是—(CH2)n—，其中n为1、2或3；X3是化学键，—O—，—S—，—OCH2—或—NH—；R1是苯基或吡啶基，每个基上可能有一个或两个亚基，如羟基、卤素等；R2是氢、（低）烷氧羰基等；R3是羟基（低）烷基、卤代（低）烷基等；R4是芳基或不饱和杂环基，每个基上可能有一个或两个亚基，如低烷基、羟基、氨基甲酰基、卤素、低烷氧基等；以及其盐，可用作药物。
• [EN] SMALL MOLECULE MODULATORS OF IL-17<br/>[FR] MODULATEURS D'IL-17 À PETITES MOLÉCULES
  申请人：LEO PHARMA AS

  公开号：WO2020182666A1

  公开（公告）日：2020-09-17

  The present invention relates to a compound according to formula I and pharmaceutically acceptable salts, hydrates, or solvates thereof. The invention further relates to, to said compounds for use in therapy, to pharmaceutical compositions comprising said compounds, to methods of treating diseases, e.g. dermal diseases, with said compounds, and to the use of said compounds in the manufacture of medicaments.

  本发明涉及按照式I的化合物及其药学上可接受的盐、水合物或溶剂化合物。该发明进一步涉及将这些化合物用于治疗、包含这些化合物的药物组合物、使用这些化合物治疗疾病（例如皮肤疾病）的方法，以及将这些化合物用于制造药物。
• N-acyl amino acid compounds and methods of use
  申请人：Pliant Therapeutics, Inc.

  公开号：US10604520B2

  公开（公告）日：2020-03-31

  The invention relates to compounds of formula (I): or a salt thereof, wherein R1, A, L, and R2 and n are as described herein. Compounds of formula (I) and pharmaceutical compositions thereof are αvβ1 integrin inhibitors that are useful for treating tissue specific fibrosis.

  本发明涉及式 (I) 化合物： 或其盐，其中 R1、A、L 和 R2 及 n 如本文所述。式（I）化合物及其药物组合物是αvβ1整合素抑制剂，可用于治疗组织特异性纤维化。
• Small molecule modulators of IL-17
  申请人：LEO Pharma A/S

  公开号：US11377425B1

  公开（公告）日：2022-07-05

  The present invention relates to a compound according to formula I and pharmaceutically acceptable salts, hydrates, or solvates thereof. The invention further relates to said compounds for use in therapy, to pharmaceutical compositions comprising said compounds, to methods of treating diseases, e.g. dermal diseases, with said compounds, and to the use of said compounds in the manufacture of medicaments.

  本发明涉及一种符合式 I 的化合物 及其药学上可接受的盐、水合物或溶液。本发明还涉及用于治疗的所述化合物、包含所述化合物的药物组合物、用所述化合物治疗疾病（如皮肤病）的方法，以及在制造药物时使用所述化合物。